These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32299128)

  • 41. Minimally Invasive Facial Cosmetic Procedures for the Millennial Aesthetic Patient.
    Mobayed N; Nguyen JK; Jagdeo J
    J Drugs Dermatol; 2020 Jan; 19(1):100-103. PubMed ID: 32395973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers.
    Nanda S; Bansal S
    Indian J Dermatol Venereol Leprol; 2013; 79(1):32-40. PubMed ID: 23254727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complications of botulinum toxin and fillers: A narrative review.
    Kassir M; Gupta M; Galadari H; Kroumpouzos G; Katsambas A; Lotti T; Vojvodic A; Grabbe S; Juchems E; Goldust M
    J Cosmet Dermatol; 2020 Mar; 19(3):570-573. PubMed ID: 31889407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific aspects of a combined approach to male face correction: botulinum toxin A and volumetric fillers.
    Scherer MA
    J Cosmet Dermatol; 2016 Dec; 15(4):566-574. PubMed ID: 27435511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Wrinkle fillers in cosmetic facial procedures].
    Jaspers GW; Schepers RH; Pijpe J; Jansma J
    Ned Tijdschr Tandheelkd; 2014 May; 121(5):269-74. PubMed ID: 24881255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and durability of hyaluronic acid fillers for malar enhancement: A prospective, randomized, split-face clinical controlled trial.
    Jeong KH; Gwak MJ; Moon SK; Lee SJ; Shin MK
    J Cosmet Laser Ther; 2018 Jun; 20(3):184-188. PubMed ID: 28135883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incorporating Minimally Invasive Procedures into an Aesthetic Surgery Practice.
    Matarasso A; Nikfarjam J; Abramowitz L
    Clin Plast Surg; 2016 Jul; 43(3):449-57. PubMed ID: 27363759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonsurgical correction of drooping mouth corners using monophasic hyaluronic acid and incobotulinumtoxinA.
    Bae GY; Na JI; Park KC; Cho SB
    J Cosmet Dermatol; 2020 Feb; 19(2):338-345. PubMed ID: 31125173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knowledge and attitude of dentists towards the use of botulinum toxin and dermal fillers in dentistry, Riyadh, Saudi Arabia.
    Al Hamdan EM; Algheryafi AM; Al-Ghareeb FJ; Ashri NY
    J Cosmet Laser Ther; 2013 Feb; 15(1):46-54. PubMed ID: 23368690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 infection-associated hypersensitivity reaction to dermal filler-A case report and review of the histologic features.
    Liu L; Ledinh W
    J Cosmet Dermatol; 2022 Sep; 21(9):3673-3674. PubMed ID: 35751425
    [No Abstract]   [Full Text] [Related]  

  • 52. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rheologic properties of soft tissue fillers and implications for clinical use.
    Heitmiller K; Ring C; Saedi N
    J Cosmet Dermatol; 2021 Jan; 20(1):28-34. PubMed ID: 32413205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on hyaluronic acid fillers for facial rejuvenation.
    Mansouri Y; Goldenberg G
    Cutis; 2015 Aug; 96(2):85-8. PubMed ID: 26367746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cosmetic complications: rare and serious events following botulinum toxin and soft tissue filler administration.
    Sorensen EP; Urman C
    J Drugs Dermatol; 2015 May; 14(5):486-91. PubMed ID: 25942667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dermal fillers may induce late-onset adverse skin reactions in patients under BRAF inhibitors.
    Ortiz-Brugués A; Bosch-Amate X; Vargas-Mora P; Gómez S; Giavedoni P; Carrera C
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e732-e734. PubMed ID: 32346875
    [No Abstract]   [Full Text] [Related]  

  • 57. What are the necessary practice competencies for two providers: dermal fillers and botulinum toxin type A injections?
    Spear M
    Plast Surg Nurs; 2010; 30(4):226-46; quiz 247-8. PubMed ID: 21217370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact on the Quality of Life Following Minimally Invasive Cosmetic Procedures: Assessment Through the Skin Rejuvenation Outcome Evaluation Questionnaire.
    Barbeito de Vasconcellos J; Alves Pereira Antelo D; Orofino-Costa R
    Dermatol Surg; 2022 Oct; 48(10):1092-1096. PubMed ID: 36036975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Creating Ideal Lips with Toxins and Fillers.
    Loyo M; Kontis T
    Facial Plast Surg Clin North Am; 2022 Aug; 30(3):365-374. PubMed ID: 35934438
    [No Abstract]   [Full Text] [Related]  

  • 60. Nonsurgical facial rejuvenation.
    Monheit GD
    Facial Plast Surg; 2014 Aug; 30(4):462-7. PubMed ID: 25076454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.